MCID: ADS004
MIFTS: 42

Aids Dementia Complex

Categories: Rare diseases, Mental diseases

Aliases & Classifications for Aids Dementia Complex

MalaCards integrated aliases for Aids Dementia Complex:

Name: Aids Dementia Complex 49 51 69
Aids Related Cognitive Impairment 49
Adc 49

Classifications:



External Ids:

UMLS 69 C0001849

Summaries for Aids Dementia Complex

MalaCards based summary : Aids Dementia Complex, also known as aids related cognitive impairment, is related to acquired immunodeficiency syndrome and human immunodeficiency virus type 1. An important gene associated with Aids Dementia Complex is CXCL12 (C-X-C Motif Chemokine Ligand 12), and among its related pathways/superpathways are Akt Signaling and PAK Pathway. The drugs Ritonavir and Lopinavir have been mentioned in the context of this disorder. Affiliated tissues include brain, monocytes and testes, and related phenotypes are cellular and hematopoietic system

Related Diseases for Aids Dementia Complex

Diseases related to Aids Dementia Complex via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 54)
# Related Disease Score Top Affiliating Genes
1 acquired immunodeficiency syndrome 29.5 B2M ITIH4 TNF
2 human immunodeficiency virus type 1 27.5 B2M CCR3 CXCL12 CXCR4 ITIH4 TNF
3 aids - neurological complications 11.0
4 leukoencephalopathy with ataxia 11.0
5 dementia 10.9
6 spondylarthropathy 10.2 B2M TNF
7 monoclonal gammopathy of uncertain significance 10.2 B2M TNF
8 post-transplant lymphoproliferative disease 10.2 B2M TNF
9 pleural tuberculosis 10.2 B2M TNF
10 orofacial granulomatosis 10.2 CCR3 TNF
11 hemorrhagic fever with renal syndrome 10.1 B2M TNF
12 retinal ischemia 10.1 CXCL12 TNF
13 ileitis 10.1 CCR3 TNF
14 inner ear disease 10.1 B2M TNF
15 encephalopathy 10.1
16 limb ischemia 10.1 CXCL12 TNF
17 peritonitis 10.1 B2M TNF
18 urinary system disease 10.0 B2M TNF
19 bronchial disease 10.0 CCR3 TNF
20 neuronitis 10.0
21 arthropathy 10.0 B2M TNF
22 multiple sclerosis 10.0
23 sarcoma 10.0
24 cerebritis 10.0
25 human herpesvirus 8 9.9
26 intraocular lymphoma 9.9 CXCL12 CXCR4
27 whim syndrome 9.9 CXCL12 CXCR4
28 lymphoplasmacytic lymphoma 9.9 CXCL12 CXCR4
29 chronic inflammatory demyelinating polyradiculoneuropathy 9.8 CXCL12 CXCR4
30 avoidant personality disorder 9.8 CXCL12 CXCR4
31 retinal hemangioblastoma 9.8 CXCL12 CXCR4
32 macroglobulinemia 9.8 CXCL12 CXCR4
33 alzheimer disease 9.7
34 schizophrenia 9.7
35 brain injury 9.7
36 hydrocephalus 9.7
37 traumatic brain injury 9.7
38 dystonia 9.7
39 cocaine abuse 9.7
40 chronic fatigue syndrome 9.7
41 encephalitis 9.7
42 toxoplasmosis 9.7
43 cerebral atrophy 9.7
44 myoclonus 9.7
45 hemophagocytic lymphohistiocytosis 9.7 B2M TNF
46 myeloma, multiple 9.6 B2M CXCR4
47 lymphoma, non-hodgkin, familial 9.5 B2M CXCL12 CXCR4
48 leukemia, acute myeloid 9.5 CXCL12 CXCR4 TNF
49 viral infectious disease 9.5 CXCR4 ITIH4 TNF
50 leukemia, chronic lymphocytic 9.4 B2M CXCL12 CXCR4

Graphical network of the top 20 diseases related to Aids Dementia Complex:



Diseases related to Aids Dementia Complex

Symptoms & Phenotypes for Aids Dementia Complex

MGI Mouse Phenotypes related to Aids Dementia Complex:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 9.8 B2M CCR3 CXCL12 CXCR4 ITIH4 TNF
2 hematopoietic system MP:0005397 9.65 CXCL12 CXCR4 TNF B2M CCR3
3 immune system MP:0005387 9.55 B2M CCR3 CXCL12 CXCR4 TNF
4 liver/biliary system MP:0005370 9.26 B2M CXCL12 ITIH4 TNF
5 neoplasm MP:0002006 8.92 B2M CXCR4 ITIH4 TNF

Drugs & Therapeutics for Aids Dementia Complex

Drugs for Aids Dementia Complex (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 122)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ritonavir Approved, Investigational Phase 4,Phase 2,Phase 3 155213-67-5 392622
2
Lopinavir Approved Phase 4,Phase 2,Phase 3 192725-17-0 92727
3
Darunavir Approved Phase 4,Phase 2,Phase 3 635728-49-3, 206361-99-1 213039
4
Epinephrine Approved, Vet_approved Phase 4 51-43-4 5816
5
Formaldehyde Approved, Vet_approved Phase 4 50-00-0 712
6 Racepinephrine Approved Phase 4 329-65-7
7
Cobicistat Approved Phase 4 1004316-88-4
8 Anti-HIV Agents Phase 4,Phase 3,Phase 2,Phase 1
9 Atorvastatin Calcium Phase 4 134523-03-8
10
protease inhibitors Phase 4,Phase 2,Phase 3,Phase 1
11 Cytochrome P-450 CYP3A Inhibitors Phase 4,Phase 2,Phase 3
12 HIV Protease Inhibitors Phase 4,Phase 2,Phase 3,Phase 1
13 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 2,Phase 3
14 Hydroxymethylglutaryl-CoA Reductase Inhibitors Phase 4
15 Anticholesteremic Agents Phase 4
16 Pharmaceutical Solutions Phase 4,Phase 2,Phase 1
17 Hypolipidemic Agents Phase 4
18 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
19 Antimetabolites Phase 4,Phase 3,Phase 2,Phase 1
20 Anti-Retroviral Agents Phase 4,Phase 3,Phase 2,Phase 1
21 Lipid Regulating Agents Phase 4
22 Calcium, Dietary Phase 4,Phase 1
23 Antiviral Agents Phase 4,Phase 3,Phase 2,Phase 1
24 Vasoconstrictor Agents Phase 4
25 Epinephryl borate Phase 4
26
Dopamine Approved Phase 3,Phase 2 51-61-6, 62-31-7 681
27
Methylphenidate Approved, Investigational Phase 3 20748-11-2, 113-45-1 4158
28
Saquinavir Approved, Investigational Phase 2, Phase 3 127779-20-8 60787
29
Amprenavir Approved, Investigational Phase 2, Phase 3 161814-49-9 65016
30
Nelfinavir Approved Phase 2, Phase 3 159989-64-7 64143
31
Efavirenz Approved, Investigational Phase 2, Phase 3 154598-52-4 64139
32
Nevirapine Approved Phase 2, Phase 3 129618-40-2 4463
33
Zidovudine Approved Phase 3,Phase 2,Phase 1 30516-87-1 35370
34
Lamivudine Approved, Investigational Phase 2, Phase 3,Phase 1 134678-17-4 60825
35
Stavudine Approved, Investigational Phase 3 3056-17-5 18283
36
Abacavir Approved, Investigational Phase 3,Phase 2 136470-78-5 441300 65140
37
Maraviroc Approved, Investigational Phase 2, Phase 3 376348-65-1 3002977
38
Enfuvirtide Approved, Investigational Phase 2, Phase 3 159519-65-0 16130199
39
Etravirine Approved Phase 2, Phase 3 269055-15-4 193962
40
Tipranavir Approved, Investigational Phase 2, Phase 3 174484-41-4 65027
41
Delavirdine Approved Phase 2, Phase 3 136817-59-9 5625
42
Emtricitabine Approved, Investigational Phase 2, Phase 3 143491-57-0 60877
43
Fosamprenavir Approved Phase 2, Phase 3 226700-79-4 131536
44 Central Nervous System Stimulants Phase 3
45 Neurotransmitter Agents Phase 3,Phase 2
46 Neurotransmitter Uptake Inhibitors Phase 3
47 Dopamine Agents Phase 3,Phase 2
48 Dopamine Uptake Inhibitors Phase 3
49
Tenofovir Phase 2, Phase 3 147127-20-6 464205
50 Raltegravir Potassium Phase 2, Phase 3

Interventional clinical trials:

(show all 41)

# Name Status NCT ID Phase Drugs
1 Modulation of Monocyte Activation by Atorvastatin in HIV Infection Completed NCT01263938 Phase 4 Atorvastatin
2 Downmodulating Monocyte Activation for HIV-1 Associated Neurocognitive Disorders (HAND) Completed NCT01600170 Phase 4 Atorvastatin (generic Lipitor);placebo
3 SOLFAMU Study of Nasal Brushing Collected OLFActory MUcosa Samples in the Diagnosis of Human Encephalopathies Recruiting NCT02951559 Phase 4
4 Effect of Cobicistat Versus Ritonavir Boosting on the Brain Permeation of Darunavir in HIV-infected Individuals Terminated NCT02503462 Phase 4 Darunavir;ritonavir;cobicistat
5 HIV - Monotherapy in Switzerland (MOST-ch) Terminated NCT00531986 Phase 4 Lopinavir-Monotherapy;HAART
6 A Study Comparing Long-acting Methylphenidate (ConcertaTM) vs. Placebo in the Treatment of Memory Loss Due to HIV Unknown status NCT01599975 Phase 3 Long acting methylphenidate;Long acting methylphenidate;Matched placebo
7 A Multicenter Placebo-Controlled Double-Blind Trial to Evaluate Azidothymidine (AZT) Treatment of the AIDS Dementia Complex and Central Nervous System (CNS) Human Immunodeficiency Virus (HIV) Infection Completed NCT00000702 Phase 3 Zidovudine
8 An Open Trial of Zidovudine (AZT) Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4+ Lymphocyte Counts Completed NCT00000709 Phase 3 Zidovudine
9 A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex Completed NCT00002246 Phase 3 Stavudine
10 A Phase III, Randomized, Double-Blind, Multicentre Study to Evaluate the Safety and Efficacy of 1592U89 in Patients With AIDS Dementia Complex Completed NCT00002163 Phase 3 Abacavir sulfate
11 Clinical Trial of CNS-targeted HAART (CIT2) Completed NCT00624195 Phase 2, Phase 3 FDA Approved Antiretroviral Therapy (see list below)
12 Maraviroc and NeuroAIDS Pathogenesis Recruiting NCT02159027 Phase 2, Phase 3 Maraviroc;Placebo
13 Safety and Effectiveness of Giving CPI-1189 to HIV-Infected Patients With AIDS Dementia Unknown status NCT00002414 Phase 2 CPI-1189
14 Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex Completed NCT00000657 Phase 2 Zidovudine;Didanosine
15 A Study to Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC) Completed NCT00000867 Phase 2 Memantine
16 Ferumoxytol-enhanced Imaging and Mapping in neuroAIDS Completed NCT02678767 Phase 2 Ferumoxytol
17 Effect of Cenicriviroc on HIV Neurocognitive Impairment Completed NCT02128828 Phase 2 cenicriviroc
18 A Study of Thioctic Acid and Deprenyl in HIV-Infected Patients With Dementia Completed NCT00002154 Phase 2 Thioctic acid;Selegiline hydrochloride
19 Safety and Effectiveness of the Selegiline "Patch" for Decreased Mental Function in HIV Patients Completed NCT00013585 Phase 2 Selegiline hydrochloride
20 Effect of Galantamine on Inflammation and Cognition Recruiting NCT03384784 Phase 2 Galantamine;Placebo
21 Intranasal Insulin for the Treatment of HAND Recruiting NCT03081117 Phase 1, Phase 2 Insulin, intranasal;Placebo, intranasal
22 Minocycline for HIV+ Cognitive Impairment in Uganda Terminated NCT00855062 Phase 1, Phase 2 minocycline;minocycline placebo capsule
23 Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1 Completed NCT00000738 Phase 1 Nimodipine;Zidovudine
24 Safety and Effectiveness of CPI-1189 in HIV-Infected Males on Combination Anti-HIV Drug Therapy Completed NCT00002209 Phase 1 CPI-1189
25 Parallel Group, Placebo-Controlled, Tolerability, Safety, and Efficacy Study of OPC-14117 in HIV Dementia Completed NCT00002148 Phase 1 OPC 14117
26 Ferumoxytol-enhanced Brain MRI in HIV-associated Neurocognitive Disorders Completed NCT01665846 Phase 1 Ferumoxytol
27 A Prospective Observational Trial to Determine Cardiovascular Diseases in HIV-infected Patients Unknown status NCT02291081
28 A Pilot Study To Evaluate the Effect of Retrovir (Zidovudine: AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Associated Dementia and Neuromuscular Diseases Completed NCT00002044 Zidovudine
29 HIV-1 Specific Immune Responses in Thai Individuals With HIV Dementia Completed NCT00777426
30 A Third-Party Blinded, Placebo Controlled Comparative Study of AS-101 Administered Intravenously in HIV Positive Patients With Advanced Disease Completed NCT00002033 Zidovudine;AS-101
31 The Prevalence of Neurocognitive Disorder in a Primary Care-based HIV Cohort Compared to a HIV-negative Control Cohort - Completed NCT01434563
32 A Study of Decreased Mental Function Associated With HIV Completed NCT00027040 Selegiline hydrochloride
33 Neurocognitive Impairment and Psychiatric Comorbidities in HIV-1 Completed NCT00476671
34 Evaluation of the Role of OCT in the Detection of HIV-associated Neurocognitive Disorder Recruiting NCT02431091
35 Mental Ability Challenge Study in Adults With and Without HIV Recruiting NCT03244488 Scopolamine Injectable Product;Mecamylamine Pill
36 Individualized Cognitive Training in HIV Recruiting NCT03122288
37 Positron Emission Tomography (PET) Imaging of Glial Activation in Psychotic Disease States Active, not recruiting NCT03257592
38 Prevalence and Predictors of Neurocognitive Impairment Among HIV-infected Patients Active, not recruiting NCT00893815
39 Mild Neurocognitive Disorder in HIV Infection of the Brain Terminated NCT01547754
40 PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD) Terminated NCT00459693 [11C]PBR28
41 Efficacy of Neuro-HAART in Patients With HIV Terminated NCT01434654

Search NIH Clinical Center for Aids Dementia Complex

Genetic Tests for Aids Dementia Complex

Anatomical Context for Aids Dementia Complex

MalaCards organs/tissues related to Aids Dementia Complex:

38
Brain, Monocytes, Testes, T Cells, Cortex

Publications for Aids Dementia Complex

Articles related to Aids Dementia Complex:

(show top 50) (show all 188)
# Title Authors Year
1
Development and in vivo evaluation of an implantable nano-enabled multipolymeric scaffold for the management of AIDS dementia complex (ADC). ( 26456249 )
2015
2
Effects of HIV-1 tat on secretion of TNF-I+ and IL-1I^ by U87 cells in AIDS patients with or without AIDS dementia complex. ( 24625401 )
2014
3
CNS toxoplasmosis induced hydrocephalus revisited and a brief review of AIDS dementia complex. ( 23749026 )
2013
4
What's in a name? AIDS dementia complex, HIV-associated dementia, HIV-associated neurocognitive disorder or HIV encephalopathy. ( 22722724 )
2012
5
HIV-1B gp120 genes from one patient with AIDS dementia complex can affect the secretion of tumor necrosis factor and interleukin 1I^ in glial cells. ( 22340390 )
2011
6
Formulation development and in vitro evaluation of didanosine-loaded nanostructured lipid carriers for the potential treatment of AIDS dementia complex. ( 20923388 )
2011
7
Memantine for AIDS dementia complex: open-label report of ACTG 301. ( 20400412 )
2010
8
Validity of the CogState brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex. ( 19395350 )
2009
9
High level HIV-1 DNA concentrations in brain tissues differentiate patients with post-HAART AIDS dementia complex or cardiovascular disease from those with AIDS. ( 19641870 )
2009
10
[Analysis of genetic diversity and biological functional site of HIV-1 gp120 from a patient with AIDS dementia complex]. ( 19634757 )
2009
11
Adjunctive therapies for AIDS dementia complex. ( 18646159 )
2008
12
Prevalence of AIDS dementia complex: results from a statewide population-based registry of Alzheimer's disease and related disorders. ( 19058735 )
2008
13
Communication impairment in the AIDS dementia complex (ADC): a case report. ( 18242630 )
2008
14
Factors in AIDS dementia complex trial design: results and lessons from the abacavir trial. ( 17401456 )
2007
15
AIDS dementia complex in China. ( 17070055 )
2007
16
AIDS dementia complex and Hashimoto encephalopathy in a senescent woman. ( 18033678 )
2007
17
Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex. ( 17492593 )
2007
18
Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex. ( 18808988 )
2007
19
Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity. ( 17827413 )
2007
20
AIDS dementia complex. ( 18808977 )
2007
21
SV40 and HIV sequences in the cerebrospinal fluid of a patient with AIDS dementia complex. ( 17504176 )
2007
22
Timed Gait test: normative data for the assessment of the AIDS dementia complex. ( 16840235 )
2006
23
The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery. ( 16343841 )
2006
24
Editorial comment: AIDS dementia complex in the current era. ( 17152650 )
2006
25
AIDS dementia complex. ( 16909695 )
2006
26
Inflammation and neuroaxonal injury in multiple sclerosis and AIDS dementia complex: implications for neuroprotective treatment. ( 16138246 )
2005
27
CSF amyloid beta42 and tau levels correlate with AIDS dementia complex. ( 16275845 )
2005
28
The AIDS dementia complex: clinical and basic neuroscience with implications for novel molecular therapies. ( 16260383 )
2005
29
Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients. ( 16010165 )
2005
30
Quinolinic acid selectively induces apoptosis of human astrocytes: potential role in AIDS dementia complex. ( 16042813 )
2005
31
HAART & the molecular biology of AIDS dementia complex. ( 15817943 )
2005
32
Involvement of quinolinic acid in AIDS dementia complex. ( 15639803 )
2005
33
Olfactory deficits in HIV-infected patients with and without AIDS dementia complex. ( 14984801 )
2004
34
Regional patterns of brain metabolites in AIDS dementia complex. ( 15528093 )
2004
35
Chemokine receptors, neural progenitor cells, and the AIDS dementia complex. ( 15216453 )
2004
36
The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations. ( 15122709 )
2004
37
Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. ( 15075501 )
2004
38
SDF-1alpha is expressed in astrocytes and neurons in the AIDS dementia complex: an in vivo and in vitro study. ( 12834106 )
2003
39
A multi-center 1H MRS study of the AIDS dementia complex: validation and preliminary analysis. ( 12766890 )
2003
40
Cytokines and AIDS dementia complex. ( 12478083 )
2003
41
Clinical aspects of the AIDS dementia complex in relation to histopathological and immunohistochemical variables. ( 11914551 )
2002
42
Screening for the AIDS dementia complex. ( 11862659 )
2002
43
Involvement of dopamine in the progression of AIDS Dementia Complex. ( 11956960 )
2002
44
Transforming growth factor beta-1 and interferon-alpha in the AIDS dementia complex (ADC): possible relationship with cerebral viral load? ( 11282546 )
2001
45
Cerebrospinal fluid S-100beta and its relationship with AIDS dementia complex. ( 11564589 )
2001
46
Varied tropism of HIV-1 isolates derived from different regions of adult brain cortex discriminate between patients with and without AIDS dementia complex (ADC): evidence for neurotropic HIV variants. ( 11162807 )
2001
47
Elevated levels of soluble Fas and Fas ligand in cerebrospinal fluid of patients with AIDS dementia complex. ( 11240032 )
2001
48
Markers of AIDS dementia complex: the role of cerebrospinal fluid assays. ( 11579253 )
2001
49
Kaposi's sarcoma and human herpesvirus 8 infection do not protect HIV-1 infected homosexual men from AIDS dementia complex. ( 11684936 )
2001
50
HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with Abacavir. ( 11371689 )
2001

Variations for Aids Dementia Complex

Expression for Aids Dementia Complex

Search GEO for disease gene expression data for Aids Dementia Complex.

Pathways for Aids Dementia Complex

Pathways related to Aids Dementia Complex according to GeneCards Suite gene sharing:

(show all 17)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.97 CCR3 CXCL12 CXCR4 TNF
2
Show member pathways
12.77 CCR3 CXCL12 CXCR4 TNF
3
Show member pathways
12.5 CCR3 CXCL12 CXCR4
4
Show member pathways
12.47 CXCL12 CXCR4 TNF
5
Show member pathways
12.3 B2M CXCL12 CXCR4 TNF
6
Show member pathways
11.79 CCR3 CXCL12 CXCR4
7 11.54 CXCL12 TNF
8 11.5 CXCL12 TNF
9 11.44 B2M CXCL12 CXCR4 TNF
10
Show member pathways
11.4 CCR3 CXCL12 CXCR4
11 11.38 CXCL12 CXCR4
12 11.29 CXCL12 CXCR4
13 11.26 CCR3 TNF
14
Show member pathways
11.22 B2M TNF
15 11.05 CXCL12 CXCR4
16 10.81 CXCL12 CXCR4
17 9.91 CXCL12 TNF

GO Terms for Aids Dementia Complex

Cellular components related to Aids Dementia Complex according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cell surface GO:0009986 9.13 B2M CXCR4 TNF
2 external side of plasma membrane GO:0009897 8.8 B2M CXCL12 TNF

Biological processes related to Aids Dementia Complex according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 immune response GO:0006955 9.58 B2M CXCL12 TNF
2 inflammatory response GO:0006954 9.5 CCR3 CXCR4 TNF
3 positive regulation of endothelial cell proliferation GO:0001938 9.37 CCR3 CXCL12
4 chemotaxis GO:0006935 9.33 CCR3 CXCL12 CXCR4
5 positive regulation of cell adhesion GO:0045785 9.26 CXCL12 TNF
6 response to virus GO:0009615 9.13 CXCL12 CXCR4 TNF
7 chemokine-mediated signaling pathway GO:0070098 8.8 CCR3 CXCL12 CXCR4

Molecular functions related to Aids Dementia Complex according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 chemokine receptor activity GO:0004950 8.96 CCR3 CXCR4
2 C-C chemokine binding GO:0019957 8.62 CCR3 CXCR4

Sources for Aids Dementia Complex

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....